BioCardia, Inc. (BCDA) vs PAVmed Inc. (PAVM)
A side-by-side comparison of BioCardia, Inc. and PAVmed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCDA
BioCardia, Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PAVM
PAVmed Inc.
$2.68HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BCDA vs PAVM
growth of $100 · dividends reinvested · last 10yBCDA -99.8% (-46.5%/yr)PAVM -100.0% (-54.0%/yr)BCDA compounded faster over this window
BCDA PAVM
BCDA vs PAVM: by the numbers
- •PAVM is the larger company ($17M vs $16M market cap).
- •Both run net losses; BCDA's is the smaller (0.00% vs -10794.64% net margin).
Metrics side by side
Valuation
| Metric | BCDA | PAVM |
|---|---|---|
| P/S ratio | N/A | 152.45 |
| P/B ratio | 5.84 | 0.55 |
Profitability
| Metric | BCDA | PAVM |
|---|---|---|
| Gross margin | 0.00% | -354.93% |
| Operating margin | 0.00% | -30712.68% |
| Net margin | 0.00% | -10794.64% |
| ROE | -271.81% | -34.50% |
| ROIC | -273.70% | -73.92% |
Growth (annualized)
| Metric | BCDA | PAVM |
|---|---|---|
| Total return CAGR (5Y) | -61.39% | -76.55% |
Frequently asked
- How have BCDA and PAVM total returns compared?
- Over the past 10 years, BCDA delivered -46.74% and PAVM delivered -54.03% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.